GRTX

Galera Therapeutics Inc
2.44
0.30 (14.02%)

Galera Therapeutics Inc. (GRTX) Fundamentals

Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer.
SHARE INFORMATION
Market Cap$ 60,990,141
Shares Outstanding28,500,066
Float25,025,749
Percent Float87.81%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -3.12
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions78
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months108,517
Institutional Holdings Percent43.8%
Institutional Sold Previous 3 Months177,702
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months10,000
Insider Holdings Percent1.4
Insider Sold Previous 3 Months10,000
Insider Shares Owned402,560
TRADING INFO
52 Week High$ 2.85
52 Week Low$ 1.12
52 Week High Change$ -10.08
21 Day Moving Average$ 1.8967
21 Day Extended Moving Average$ 1.963
50 Day Moving Average$ 1.7368
50 Day Extended Moving Average$ 1.8025
200 Day Moving Average$ 1.59
200 Day Extended Moving Average$ 2.0147
10 Day Average Volume154,759
20 Day Average Volume146,762
30 Day Average Volume132,621
50 Day Average Volume112,426
Alpha0.005703
Beta1.4690
Standard Deviation0.476194
R20.034609
7 Day Price Change$ 0.04
7 Day Percent Change1.9%
21 Day Price Change$ 0.48
21 Day Percent Change28.92%
30 Day Price Change$ 0.68
30 Day Percent Change46.58%
Month to Date Price Change$ 0.65
Month to Date Percent Change43.62%
Quarter to Date Price Change$ 0.65
Quarter to Date Percent Change43.62%
180 Day Price Change$ 0.9715
180 Day Percent Change83.14%
200 Day Price Change$ 0.81
200 Day Percent Change60.9%
Year to Date Price Change$ 0.65
Year to Date Percent Change43.62%

Galera Therapeutics Inc. (GRTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.60
Total Debt To Equity0.10
Int Coverage-5.00
Current Ratio3.90
Leverage Ratio-0.70
Quick Ratio3.70
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio-0.90
Enterprise Value$ 18,330,141
Price to Sales0.00
Price to Free Cash-2.10
PE High Last 5 Years0.00
Price To Book29.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-84.08
Return on Equity89.35
Return on Capital-927.97

Galera Therapeutics Inc. (GRTX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOJ. Mel Sorensen
Emplyoees30
Last AuditUQ
CIK0001563577
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2 West Liberty Boulevard
Suite 100
Malvern, PA 19355
Websitehttps://www.galeratx.com
Facsimile-
Telephone+1 610 725-1500
Emailcdegnan@galeratx.com


Your Recent History
NASDAQ
GRTX
Galera The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.